Page last updated: 2024-12-06

chavicol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Chavicol, also known as estragole, is a phenylpropene derivative with a pleasant, sweet, licorice-like aroma. It is a naturally occurring compound found in various plants, including basil, tarragon, and star anise. Chavicol is synthesized through the condensation of cinnamaldehyde with sodium hydroxide. It has been shown to exhibit a range of biological activities, including antioxidant, anti-inflammatory, and antimicrobial properties. Its antifungal and antibacterial activities against various pathogens make it a potential candidate for the development of new antimicrobial agents. Chavicol's ability to inhibit the growth of certain cancer cell lines has also been investigated. Additionally, it is studied for its potential role in plant defense mechanisms. The compound is also used as a flavoring agent in the food industry.'

4-allylphenol: an inhibitor of aryl-alcohol oxidase; has free radical scavenging activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

chavicol : A phenylpropanoid that is phenol substituted by a prop-2-enyl group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID68148
CHEMBL ID108862
CHEBI ID50158
SCHEMBL ID30870

Synonyms (51)

Synonym
4-(prop-2-enyl)-phenol
4-(2-propenyl)phenol
p-chavicol
CHEBI:50158 ,
phenol, p-allyl-
p-allylphenol
nsc-290195
chavicol
nsc290195
501-92-8
4-allylphenol
p-hydroxyallylbenzene
.gamma.-(p-hydroxyphenyl)-.alpha.-propylene
phenol, 4-(2-propenyl)-
gamma-(p-hydroxyphenyl)-alpha-propylene
ccris 3208
einecs 207-929-2
nsc 290195
inchi=1/c9h10o/c1-2-3-8-4-6-9(10)7-5-8/h2,4-7,10h,1,3h2
rgibxdhonmxtli-uhfffaoysa-
4-allyl-phenol
CHEMBL108862
4-prop-2-enylphenol
C16930
AKOS006278514
unii-q5er4k6969
q5er4k6969 ,
chavicol [mi]
fema no. 4075
4-allylphenol [fhfi]
SCHEMBL30870
4-(prop-2-en-1-yl)phenol
DTXSID60198210
mfcd01940501
3-(4-hydroxyphenyl)-1-propene
alpha -propylene
4-(2-propenyl)-phenol
laquo gammaraquo -(p-hydroxyphenyl)-alpha -propylene
3-(p-hydroxyphenyl)-1-propene
phenol, p-allyl- (8ci)
p-allyl-phenol
p-hydroxyallylpropene
phenol, 4-(2-propenyl)- (9ci)
SY045829
Q2504388
AC1877
EN300-698378
CS-12298
A917800
CS-0217169
C3743
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
phenylpropanoidAny organic aromatic compound with a structure based on a phenylpropane skeleton. The class includes naturally occurring phenylpropanoid esters, flavonoids, anthocyanins, coumarins and many small phenolic molecules as well as their semi-synthetic and synthetic analogues. Phenylpropanoids are also precursors of lignin.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
volatile cinnamoic ester biosynthesis016
furcatin degradation17
volatile cinnamoic ester biosynthesis216
furcatin degradation18

Bioassays (5)

Assay IDTitleYearJournalArticle
AID247905Cytotoxicity of compound against human liver tumor cell line (Hep-G2) was determined2005Bioorganic & medicinal chemistry letters, Jan-03, Volume: 15, Issue:1
Cytotoxic neolignans: an SAR study.
AID1110759Nematocidal activity against Caenorhabditis elegans assessed as mortality2002Annual review of phytopathology, , Volume: 40Phytochemical based strategies for nematode control.
AID166551Percentage inhibition against release of beta-hexosaminidase from RBL-2H3 cells at 100 uM from control2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-alpha and IL-4 in RBL-2H3 cells.
AID252044Percent inhibition of nitric oxide (NO) production in lipopolysaccharide activated mouse peritoneal macrophages at 100 uM of compound2005Bioorganic & medicinal chemistry letters, Apr-01, Volume: 15, Issue:7
Structure-activity relationships of 1'S-1'-acetoxychavicol acetate for inhibitory effect on NO production in lipopolysaccharide-activated mouse peritoneal macrophages.
AID248765Inhibitory concentration of compound on nitric oxide (NO) production in lipopolysaccharide activated mouse peritoneal macrophages2005Bioorganic & medicinal chemistry letters, Apr-01, Volume: 15, Issue:7
Structure-activity relationships of 1'S-1'-acetoxychavicol acetate for inhibitory effect on NO production in lipopolysaccharide-activated mouse peritoneal macrophages.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's2 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.63 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index90.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]